A new study published in “The Lancet Neurology” investigates whether azathioprine, a common immunosuppressant, could represent a breakthrough in slowing the progression of Parkinson’s Disease...
We are pleased to announce that the fourth and final Annual Conference of the IMMUPARKNET Action will take place in Coimbra, Portugal, from 12 to...
We are pleased to announce that the call for grant applications for Grant Period 4 of ImmuParkNet is now open. This call covers activities to...
We’re thrilled to share the latest publication from our Working Group 3 (WG3) at IMMUPARKNET COST Action 21117, published in npj Parkinson’s Disease! Entitled “Recommendations...
We invite you to a stimulating discussion on May 15, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...
We invite you to a stimulating discussion on January 23, 2025, at 3:00 PM CET, organized as part of the COST Action CA21117. This online...
Our Action Chair, Cristoforo Comi, Professor of Neurology at the University of Eastern Piedmont in Italy, participated in the “Inflammation Phenotyping Workshop” organized by the...
IMMUPARKNET COST Action recently concluded the first training school entitled “Models for Parkinson’s Disease: From Basics to Translation” held at the Faculty of Health Sciences,...
Short-term Scientific Missions (STSM) are institutional visits aimed at supporting individual mobility and fostering collaborations by allowing scientists to visit an institution and contribute to...
We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction...
🎉 Exciting News from IMMUPARKNET COST Action 21117 Annual Meeting! 🎉 This year’s IMMUPARKNET COST Action Annual Conference took place in the beautiful city of...
🧠 Neuroscience Academy Denmark Lecture on Parkinson’s Disease 🧠 🗓 Date & Time: March 22, 2024, 1:00 pm (CET) 🌐 Location: Aarhus University, Building 1613,...